Angiogenesis in colorectal cancer: therapeutic implications and future directions.

Rangaswamy Govindarajan, Irinotecan/thalidomide in metastatic colorectal cancer. Oncology. ,vol. 14, pp. 29- 32 ,(2002)

Yukio Chiba, Hirokazu Amaya, Tetsuya Horiuchi, Tomoaki Nakamura, Kuniyoshi Tanaka, Mitsuyosi Matsumura, Katsuya Miyanaga, Yasushi Kato, Expression and role of thrombospondin-1 in colorectal cancer. Anticancer Research. ,vol. 22, pp. 3941- 3948 ,(2002)

Lissandra Dal Lago, Marc F. Richter, Anna I. Cancela, Sabrina A. Fernandes, Keylla T. Jung, Ana C. Rodrigues, Teresa Dalla Costa, Luciane P. Di Leone, Gilberto Schwartsmann, Phase II trial and pharmacokinetic study of thalidomide in patients with metastatic colorectal cancer. Investigational New Drugs. ,vol. 21, pp. 359- 366 ,(2003) , 10.1023/A:1025485031112

Gregory D. Ayers, Edward Lin, Jeffrey S. Morris, Effect of celecoxib on capecitabine-induced hand-foot syndrome and antitumor activity. Oncology. ,vol. 16, pp. 31- 37 ,(2002)

Stefano Cascinu, Francesco Graziano, Vincenzo Catalano, Maria Pia Staccioli, Sandro Barni, Paolo Giordani, Maria Cristina Rossi, Anna Maria Baldelli, Pietro Muretto, Andrea Valenti, Giuseppina Catalano, Differences of vascular endothelial growth factor (VEGF) expression between liver and abdominal metastases from colon cancer. Implications for the treatment with VEGF inhibitors. Clinical & Experimental Metastasis. ,vol. 18, pp. 651- 655 ,(2000) , 10.1023/A:1013133224044

David Lyden, Koichi Hattori, Sergio Dias, Carla Costa, Pamela Blaikie, Linda Butros, Amy Chadburn, Beate Heissig, Willy Marks, Larry Witte, Yan Wu, Daniel Hicklin, Zhenping Zhu, Neil R. Hackett, Ronald G. Crystal, Malcolm A.S. Moore, Katherine A. Hajjar, Katia Manova, Robert Benezra, Shahin Rafii, Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth Nature Medicine. ,vol. 7, pp. 1194- 1201 ,(2001) , 10.1038/NM1101-1194

Wei Zhang, Sophia Ran, M. Sambade, Xianming Huang, Philip E. Thorpe, A monoclonal antibody that blocks VEGF binding to VEGFR2 (KDR/Flk-1) inhibits vascular expression of Flk-1 and tumor growth in an orthotopic human breast cancer model. Angiogenesis. ,vol. 5, pp. 35- 44 ,(2002) , 10.1023/A:1021540120521

Christodoulos Stefanadis, Christina Chrysohoou, Demosthenes B Panagiotakos, Elisabeth Passalidou, Vasiliki Katsi, Vlassios Polychronopoulos, Pavlos K Toutouzas, Temperature differences are associated with malignancy on lung lesions: a clinical study BMC Cancer. ,vol. 3, pp. 1- 5 ,(2003) , 10.1186/1471-2407-3-1

E. Tischer, R. Mitchell, T. Hartman, M. Silva, D. Gospodarowicz, J.C. Fiddes, J.A. Abraham, The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. Journal of Biological Chemistry. ,vol. 266, pp. 11947- 11954 ,(1991) , 10.1016/S0021-9258(18)99049-6

Shoshana Yakar, Lothar Hennighausen, Derek LeRoith, Ling Zhao, Yiping Wu, Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Research. ,vol. 62, pp. 1030- 1035 ,(2002)